$ADVM Adverum Biotechnologies, Inc. Insider Trading Week 23/2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adverum Biotechnologies, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Adverum Biotechnologies, Inc. in week 23/2015.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 11 2015 | AAVL | Adverum Biotechnol ... | GUERIN JOHN PATRICK ET AL | Director | Sell | S | 206.00 | 699 | 143,994 | 150,000 | 150.7 K to 150 K (-0.46 %) |
Jun 11 2015 | AAVL | Adverum Biotechnol ... | GUERIN JOHN PATRICK ET AL | Director | Sell | S | 208.00 | 1 | 208 | 150,699 | 150.7 K to 150.7 K (0.00 %) |
Jun 11 2015 | AAVL | Adverum Biotechnol ... | GUERIN JOHN PATRICK ET AL | Director | Sell | S | 206.00 | 1,205 | 248,230 | 150,700 | 151.9 K to 150.7 K (-0.79 %) |
Jun 11 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 39.91 | 600 | 23,948 | 524,889 | 525.5 K to 524.9 K (-0.11 %) |
Jun 11 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 37.35 | 200 | 7,470 | 525,489 | 525.7 K to 525.5 K (-0.04 %) |
Jun 11 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 36.20 | 7,000 | 253,402 | 525,689 | 532.7 K to 525.7 K (-1.31 %) |
Jun 11 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 35.52 | 15,300 | 543,456 | 532,689 | 548 K to 532.7 K (-2.79 %) |
Jun 11 2015 | AAVL | Adverum Biotechnol ... | Chalberg Thomas W. | Chief Executive Off ... | Sell | S | 38.90 | 6,995 | 272,123 | 258,988 | 266 K to 259 K (-2.63 %) |
Jun 11 2015 | AAVL | Adverum Biotechnol ... | Chalberg Thomas W. | Chief Executive Off ... | Sell | S | 38.04 | 12,970 | 493,339 | 265,983 | 279 K to 266 K (-4.65 %) |
Jun 11 2015 | AAVL | Adverum Biotechnol ... | Chalberg Thomas W. | Chief Executive Off ... | Sell | S | 36.89 | 5,035 | 185,733 | 278,953 | 284 K to 279 K (-1.77 %) |
Jun 10 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Sell | S | 39.88 | 176 | 7,019 | 38,353 | 38.5 K to 38.4 K (-0.46 %) |
Jun 10 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Sell | S | 38.96 | 475 | 18,505 | 38,529 | 39 K to 38.5 K (-1.22 %) |
Jun 10 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Sell | S | 37.96 | 541 | 20,537 | 39,004 | 39.5 K to 39 K (-1.37 %) |
Jun 10 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Option Exercise | M | 2.75 | 500 | 1,375 | 95,500 | |
Jun 10 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Sell | S | 39.88 | 82 | 3,270 | 7,000 | 7.1 K to 7 K (-1.16 %) |
Jun 10 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Sell | S | 38.95 | 183 | 7,128 | 7,082 | 7.3 K to 7.1 K (-2.52 %) |
Jun 10 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Sell | S | 37.97 | 235 | 8,923 | 7,265 | 7.5 K to 7.3 K (-3.13 %) |
Jun 10 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Buy | M | 2.75 | 500 | 1,375 | 7,500 | 7 K to 7.5 K (+7.14 %) |
Jun 08 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 40.08 | 5,000 | 200,414 | 547,989 | 553 K to 548 K (-0.90 %) |